Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02282852
Other study ID # STH17268
Secondary ID
Status Completed
Phase N/A
First received October 31, 2014
Last updated March 20, 2015
Start date January 2014
Est. completion date March 2015

Study information

Verified date October 2014
Source Sheffield Teaching Hospitals NHS Foundation Trust
Contact n/a
Is FDA regulated No
Health authority United Kingdom: Research Ethics Committee
Study type Interventional

Clinical Trial Summary

Small bowel wireless capsule endoscopy is the investigation modality of choice for suspected diseases of the small bowel. The procedure is safe and noninvasive, the main risk being capsule retention occurring in approximately 2% of procedures. Other problems such as incomplete examinations occur in 10-20% of procedures. Reasons include delayed gastric emptying, slow small bowel transit, faulty equipment and poor bowel preparation.

Some protocols identify the capsule position 30 minutes after ingestion using a 'realtime' viewer. If the capsule remains in the stomach, mobilisation is encouraged followed by an intramuscular prokinetic injection if this fails. This approach has disadvantages since an intramuscular injection is uncomfortable for patients. Additionally metoclopramide, commonly used for this purpose, has a risk of acute dystonic reactions particularly in young patients.

Recently a handheld magnet (Intromedic Ltd.) has been developed to enable control of the capsule in the upper GI tract. We propose that this could be used, alongside positional changes, to expedite capsule transit through the stomach thus improving completion rates and avoiding the risks of unnecessary medication. We wish to undertake a randomised controlled study comparing a standard protocol for small bowel capsule endoscopy against a hand held magnet and positional change protocol to enhance gastric emptying of the wireless capsule.


Recruitment information / eligibility

Status Completed
Enrollment 24
Est. completion date March 2015
Est. primary completion date March 2015
Accepts healthy volunteers No
Gender Both
Age group 20 Years and older
Eligibility Inclusion Criteria:

- Patients aged 20 years or over

- Patients attending hospital for small bowel endoscopy examination

Exclusion Criteria:

- Patients under the age of 20 years

- Patients with a permanent pacemaker, or implantable cardioverter-defibrillator

- Patients with any electronic/magnetic/mechanically controlled devices

- Patients that are pregnant

- Patients who are unable to understand or speak English

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Diagnostic


Related Conditions & MeSH terms

  • Patients Attending Hospital for Small Bowel Endoscopy

Intervention

Device:
Wireless Capsule Endoscopy

Magnetically steerable capsule endoscopy


Locations

Country Name City State
United Kingdom Royal Hallamshire Hospital Sheffield South Yorkshire

Sponsors (1)

Lead Sponsor Collaborator
Sheffield Teaching Hospitals NHS Foundation Trust

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Completion rate of small bowel endoscopy examination Baseline No
Primary Duration of time taken for camera capsule to enter duodenum. Baseline No